Press Releases
MEDLINE AND CASMED ANNOUNCE DISTRIBUTION PARTNERSHIP - Monitor features advanced non-invasive blood pressure measurement technology - Branford, CT, June 15, 2011 - Medline Industries, Inc. and CAS Medical Systems, Inc. (NASDAQ: CASM), today announced a distribution agreement for a co-branded version of CASMED's Model 740 portable vital signs monitor. The monitor will feature CASMED's proprietary Motion Artifact Extraction (MAXNIBPﾮ) technology, the most advanced technology for non-invasive blood pressure measurement. Changes in the hospital environment such as nursing shortages and the need to monitor all areas of the hospital are driving a need for more flexible solutions, said Maroun Abouzeid, President of Medline's Preferred HealthCare Products Division. CASMED brings a wealth of knowledge and innovation that will allow us to expand our diagnostic product offering within the acute care setting. All of these co-branded monitors feature CASMED's NIBP technology which has a proven reputation for fast, accurate blood pressure determinations under the most challenging conditions for patients ranging from neonatal to adult. Oximetry options include Masimo SETﾮ and Nellcorﾮ OxiMaxﾮ, making the monitor a versatile, mobile unit for diverse types of clinical applications, especially in conditions of low perfusion and motion. We are very excited about this new venture between CASMED and Medline, said Matthew J. Herwig, VP of Global Sales and Marketing for CASMED. We believe that Medline's expertise in distribution, specifically to hospitals, surgery centers and physician offices, will expand our market share and open new opportunities for our best-in-class bedside monitor and our patented blood pressure technology.
About CASMED® - Monitoring What's Vital The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter, the bedside patient monitoring line of vital signs monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates. For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com. About Medline Industries, Inc. Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians. Medline has a growing network of 50 manufacturing and distribution centers worldwide, as well as an expanding, dedicated transportation fleet with over 200 vehicles in a variety of sizes to fit customers' specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication. For more information on Medline, visit www.medline.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the result of on-going litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders and competitors and other risks detailed in the Company's Form 10-K for the year ended December 31, 2009 and other subsequent Securities and Exchange Commission filings. Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
|
